LEGN Stock Analysis: Buy, Sell, or Hold?
LEGN - Legend Biotech Corporation American Depositary Shares
$29.91
0.02 (0.07%)
▲
5d:
+5.21%
30d:
-17.56%
90d:
+57.01%
BUY
HIGH Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Get Alerted When LEGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: LEGN trading at deep discount. Market pricing in -14.8% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: LEGN trading at deep discount. Market pricing in -14.8% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$63.32
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$39.32
23.9% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LEGN is currently trading at $29.91, which is considered slightly low relative to its 30-day fair value range of $28.07 to $34.39. From a valuation perspective, the stock is trading at a discount (Forward PE: 23.0) compared to its historical average (37.2). Remarkably, the market is currently pricing in an annual earnings decline of 14.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, LEGN is in a strong uptrend. The price is approaching resistance at $30.34. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $57.24 (+91.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, LEGN is in a strong uptrend. The price is approaching resistance at $30.34. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $57.24 (+91.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$28.07 -
$34.39
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 91.4% below Wall St target ($57.24)
Trading Range Analysis
30-Day Trading Range
$28.07 -
$34.39
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$27.43
Resistance Level
$30.34
Current Trend
Strong Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
23.00
Wall Street Target
$57.24
(+91.4%)
Revenue Growth (YoY)
56.5%
Profit Margin
-22.0%
Valuation Discount vs History
-14.8% cheaper
PE vs Historical
23.0 vs 37.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-14.8%
(market-implied from PE analysis)
1-Year Target
$26.92
(-10%)
2-Year Target
$24.23
(-19%)
3-Year Target
$21.80
(-27%)
3-Yr Target (if PE normalizes)
(PE: 23→37)
$35.27
(+18%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 23.0, Growth: 364.5%)
$100.95
(+238%)
Base:
(SPY PE: 21.8, Growth: 364.5%)
$95.61
(+220%)
Bear:
(PE: 18.5, Growth: 364.5%)
$81.27
(+172%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 23.0 to 37.2
Stabilization Target:
$48.39
(+61.8%)
PE Expansion Potential:
+61.8%
Share & Embed Analysis
Last updated: July 03, 2026 4:55 PM ET
Data refreshes hourly during market hours. Next update: 5:55 PM
Data refreshes hourly during market hours. Next update: 5:55 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LEGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Ying Huang
SELL
9936 shares
2026-03-25
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 59 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 63 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 54 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$122 | 56 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$34 | 67 BUY |
